MENU
+Compare
CNTA
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$13.64
Change
+$0.61 (+4.68%)
Capitalization
1.69B

CNTA Centessa Pharmaceuticals plc Forecast, Technical & Fundamental Analysis

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company... Show more

CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CNTA with price predictions
Apr 23, 2025

CNTA's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CNTA turned positive on April 17, 2025. Looking at past instances where CNTA's MACD turned positive, the stock continued to rise in of 33 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CNTA's RSI Indicator exited the oversold zone, of 12 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on CNTA as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNTA advanced for three days, in of 196 cases, the price rose further within the following month. The odds of a continued upward trend are .

CNTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

CNTA moved below its 50-day moving average on March 25, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CNTA crossed bearishly below the 50-day moving average on March 26, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNTA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CNTA entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.322) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (243.902) is also within normal values, averaging (252.992).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CNTA is expected to report earnings to fall 57.14% to -36 cents per share on May 19

Centessa Pharmaceuticals plc CNTA Stock Earnings Reports
Q1'25
Est.
$-0.36
Q4'24
Missed
by $0.42
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.01
Q1'24
Beat
by $0.04
The last earnings report on March 24 showed earnings per share of -83 cents, missing the estimate of -41 cents. With 226.07K shares outstanding, the current market capitalization sits at 1.69B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Ashley Road
Phone
+1 617 468-5770
Employees
153
Web
https://www.centessa.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GRINX18.69N/A
N/A
Victory Diversified Stock R
ISFIX15.33N/A
N/A
VY® Columbia Contrarian Core I
IRMCX10.26N/A
N/A
Voya Russell Mid Cap Index Port S
RGBEX36.28N/A
N/A
American Funds Global Balanced R4
MSALX22.60N/A
N/A
Morgan Stanley Inst Intl Advtg L

CNTA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with XENE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
+2.84%
XENE - CNTA
43%
Loosely correlated
+2.23%
ORIC - CNTA
42%
Loosely correlated
-0.96%
CRNX - CNTA
42%
Loosely correlated
+3.55%
KYMR - CNTA
41%
Loosely correlated
+6.56%
BNTX - CNTA
40%
Loosely correlated
+9.70%
More